Progress and challenges in childhood brain tumors - PubMed
Progress and challenges in childhood brain tumors
Roger J Packer. J Neurooncol. 2005 Dec.
Abstract
Although many challenges lie ahead, there has been definite progress made in the management of childhood brain tumors. Some of these advances have increased progression-free and overall survival. Other advances, while not improving survival, have resulted in a better quality of life for long-term survivors. Probably the best example of progress is manifest in the outcome of children with medulloblastoma. Seventy percent, and in some subsets as high as 80% of children with this disease can be expected to be cured, compared to approximately 50% three decades ago. This improvement in disease control has been associated with a reduction in the dose of radiotherapy for many patients and possibly an improved quality of survival. For other tumor types, especially brain stem gliomas, there has been little progress made. A primary challenge in the years ahead will be how to integrate biologic discoveries into the care of children for brain tumors, with the hope that molecular biologically based therapy will be more effective and improve the quality of life for survivors.
Similar articles
-
Medulloblastoma: presentation, diagnosis and management.
Packer RJ, Finlay JL. Packer RJ, et al. Oncology (Williston Park). 1988 Sep;2(9):35-45, 48-9. Oncology (Williston Park). 1988. PMID: 3275066
-
Childhood brain tumors: accomplishments and ongoing challenges.
Packer RJ. Packer RJ. J Child Neurol. 2008 Oct;23(10):1122-7. doi: 10.1177/0883073808320758. J Child Neurol. 2008. PMID: 18952578 Free PMC article. Review.
-
Clinical management of medulloblastoma in adults.
Eisenstat DD. Eisenstat DD. Expert Rev Anticancer Ther. 2004 Oct;4(5):795-802. doi: 10.1586/14737140.4.5.795. Expert Rev Anticancer Ther. 2004. PMID: 15485314 Review.
-
Recent Advances in Pediatric Medulloblastoma.
Jackson K, Packer RJ. Jackson K, et al. Curr Neurol Neurosci Rep. 2023 Dec;23(12):841-848. doi: 10.1007/s11910-023-01316-9. Epub 2023 Nov 9. Curr Neurol Neurosci Rep. 2023. PMID: 37943476 Free PMC article. Review.
-
Childhood medulloblastoma: progress and future challenges.
Packer RJ. Packer RJ. Brain Dev. 1999 Mar;21(2):75-81. doi: 10.1016/s0387-7604(98)00085-0. Brain Dev. 1999. PMID: 10206522 Review.
Cited by
-
Lack of prognostic significance of survivin in pediatric medulloblastoma.
Faccion RS, Ferreira RM, Grabois MF, Fonseca TC, de Oliveira JA, Maia RC. Faccion RS, et al. Pathol Oncol Res. 2011 Dec;17(4):899-908. doi: 10.1007/s12253-011-9401-z. Epub 2011 Jun 17. Pathol Oncol Res. 2011. PMID: 21681603
-
Gudrunardottir T, Lannering B, Remke M, Taylor MD, Wells EM, Keating RF, Packer RJ. Gudrunardottir T, et al. Childs Nerv Syst. 2014 Jun;30(6):979-90. doi: 10.1007/s00381-014-2388-5. Epub 2014 Feb 26. Childs Nerv Syst. 2014. PMID: 24569911 Review.
-
Prince EW, Balakrishnan I, Shah M, Mulcahy Levy JM, Griesinger AM, Alimova I, Harris PS, Birks DK, Donson AM, Davidson N, Remke M, Taylor MD, Handler MH, Foreman NK, Venkataraman S, Vibhakar R. Prince EW, et al. Oncotarget. 2016 Aug 16;7(33):53881-53894. doi: 10.18632/oncotarget.10692. Oncotarget. 2016. PMID: 27449089 Free PMC article.
-
Medulloblastoma: clinicopathologic evaluation of 42 pediatric cases.
Ertan Y, Sezak M, Demirağ B, Kantar M, Cetingül N, Turhan T, Erşahin Y, Mutluer S, Anacak Y, Akalin T. Ertan Y, et al. Childs Nerv Syst. 2009 Mar;25(3):353-6. doi: 10.1007/s00381-008-0784-4. Epub 2009 Jan 13. Childs Nerv Syst. 2009. PMID: 19139904
-
Pinarli FG, Oguz A, Karadeniz C, Okur A, Sarac A, Baykaner K, Bora H, Poyraz A. Pinarli FG, et al. Contemp Oncol (Pozn). 2012;16(1):26-33. doi: 10.5114/wo.2012.27333. Epub 2012 Feb 29. Contemp Oncol (Pozn). 2012. PMID: 23788851 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical